Objective To describe preterm birth frequency and newborn and infant outcomes overall and among preterm children in the MATISSE (Maternal Immunization Study for Safety and Efficacy) trial of maternal vaccination with bivalent respiratory syncytial virus (RSV) prefusion F protein–based vaccine (RSVpreF) to protect infants against severe RSV-associated illness. Methods MATISSE was a global, phase 3, […]

Latest updates

From the Pakistan team

11 OCT

The Continuum of Protection: Pakistan’s Path to a Maternal RSV Vaccine

Professor Imran Nisar has spent more than thirteen years working at the intersection of epidemiology and paediatrics, an unusual vantage point from which to watch a country’s vaccine landscape evolve.   As Associate Professor (Research) and Vice Chair (Research) in the Department of Paediatrics and Child Health at Aga Khan University, his research has ranged across […]

Language access

View MIRNA content in your preferred language.

Use the language selector in the website header to translate MIRNA content across the site.

English · Kiswahili · Amharic · Bangla · Urdu · French

Partners

Pakistan network partners

Partner directory

Pakistan

Explore resources from Pakistan

Pakistan projects

Preterm Birth Frequency and Associated Outcomes From the MATISSE (Maternal Immunization Study for Safety and Efficacy) Maternal Trial of the Bivalent Respiratory Syncytial Virus Prefusion F Protein Vaccine

From the Pakistan team

View MIRNA content in your preferred language.

Pakistan network partners

MIRNA updates, evidence and opportunities